Meet In CommonNews

Local

Tenaska introduces Bess and Bobwhite at meeting

Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.

Source: The Rogersville Review

Tenaska, an energy company, gave a presentation hosted by Care NET in the Holston Electric Co-Operative (HEC) Auditorium on Monday, Nov. 9. The subject of the meeting was a new facility Tenaska is building in the Phipps Bend Industrial Park. The Bobwhite facility will be a battery energy storage system, known as BESS.Located in the southern end of the industrial park, the new construction will occupy about four acres of a six-acre plot. There will be about 75 jobs created during the two-year construction period. Bobwhite has been in the planning stages for about three years, and will begin construction in early 2028. Plans call for completion by the third quarter of 2029, with an investment by Tenaska of about $300 million.BESS provides a way to store electricity during times of low demand and provide it to the grid within seconds of high demand. At Phipps Bend, the battery collection will store about 225 MW of electricity.

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at The Rogersville Review

Featured places to meet in Omaha, NE

Explore these places and arrange a conversation through ThinkMatch.

72 Table & Tap

72 Table & Tap 5413 South 72th Street Omaha, NE, 68127-3935 US

City guide for Omaha, NE

Community Poll

Colleges should publish clear information about costs and likely graduate outcomes.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Would you want a doctor to give you a fake pill if the lie might make you feel better?

A patient has persistent symptoms that have not responded to standard treatments. A harmless placebo may help, but its effect could weaken if the clinician fully explains that it contains no active medicine.

Can a beneficial deception respect the person it helps?

Explore this quandary